title: "Neural Killer" Cells: Autologous Cytotoxic Neural Stem Cells for Fighting Glioma.
abstract: Recently in Science Translational Medicine, Bagó et al. (2017) reported an advance in treating glioblastoma using tumor-homing cytotoxic induced neural stem cells (h-iNSCTE). This approach circumvents problems associated with immune rejection and minimizes the bench-to-clinic time window critical for these patients.
authors.affiliation: Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Ihnestr. 63-73, 14195 Berlin, Germany.
authors.forename: Naresh
authors.initials: N
authors.lastname: Mutukula
authors.affiliation: Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Ihnestr. 63-73, 14195 Berlin, Germany. Electronic address: elkabetz@molgen.mpg.de.
authors.forename: Yechiel
authors.initials: Y
authors.lastname: Elkabetz
mesh_terms: D001932:Brain Neoplasms / Q000276:immunology; D005909:Glioblastoma / Q000276:immunology; D005910:Glioma / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D014411:Neoplastic Stem Cells; D058953:Neural Stem Cells